Tenofovir disoproxil fumarate

This classification denotes a reverse transcriptase inhibitor with the molecular formula C19H30N5O10P.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OTT9J7900I, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but more generally known as tenofovir disoproxil fumarate, which bears US NIH Compound Identifier 464205. European Medicines Agency schedules Tenofovir disoproxil fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12607MIG. Most nations, for tariff and trade purposes, schedule tenofovir disoproxil fumarate under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR DISOPROXIL FUMARATE remains US FDA's Preferred Term for this commodity. Tenofovir disoproxil fumarate bears US NLM identifiers UMLS ID C1099776 and NCI Concept Code C47747. SMILES: C[C@H](CN1CNC2C1NCNC2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O.